Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis
PLoS Medicine, 2011•journals.plos.org
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis |
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue
Journal Archive Special Issues Collections Find and Read Articles Publish Submissions Getting
Started Submission Guidelines Figures Tables Supporting Information LaTeX Other Article
Types Preprints Revising Your Manuscript Submit Now Policies Best Practices in Research
Reporting Human Subjects Research Animal Research Competing Interests Disclosure of …
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue
Journal Archive Special Issues Collections Find and Read Articles Publish Submissions Getting
Started Submission Guidelines Figures Tables Supporting Information LaTeX Other Article
Types Preprints Revising Your Manuscript Submit Now Policies Best Practices in Research
Reporting Human Subjects Research Animal Research Competing Interests Disclosure of …
David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.
PLOS